Neurodevelopmental disorder and juvenile-onset tics associated with microdeletion of the SRRM2 gene.

Publication date: Jun 23, 2025

SRRM2-related neurodevelopmental disorder is a recently described genetic diagnosis caused by loss-of-function variants. The clinical presentation is characterised by a developmental delay with mild intellectual disability, occasionally associated with features of autism spectrum disorder and/or attention-deficit/hyperactivity disorder, as well as inconsistent dysmorphic features, hypotonia, and obesity. We document the rare case of a 30-year-old man diagnosed with neurodevelopmental disorder and juvenile-onset tics associated with a microdeletion involving the SRRM2 gene. He initially presented with simple motor and vocal tics in early adulthood and subsequently developed handwriting tics and limb posturing (catatonic tics). Tic severity was rated as moderate-to-marked (Yale Global Tic Severity Scale score of 55/100) and treatment recommendations included alpha-2 agonists. To date, a total of 37 cases presenting with loss-of-function mutations in SRRM2 have been reported as neurodevelopmental disease-causing mutations. Of these, 21 were males and none had tics as part of their neurodevelopmental manifestations. Our case report widens the spectrum of neurodevelopmental disorders observed in the context of SRRM2 gene microdeletions and prompts further research to disentangle the contributions of genetic and environmental factors to variable phenotypic expressions.

Open Access PDF

Concepts Keywords
Autism Intellectual disability
Date Juvenile-onset tics
Microdeletions Neurodevelopmental disorder
Obesity SRRM2 gene microdeletion
Yale

Semantics

Type Source Name
disease MESH Neurodevelopmental disorder
disease MESH tics
disease MESH intellectual disability
disease MESH autism spectrum disorder
disease MESH hypotonia
disease MESH obesity
drug DRUGBANK Serine
drug DRUGBANK L-Arginine
pathway KEGG Spliceosome
disease MESH attention deficit hyperactivity disorder
disease MESH autism
disease MESH Tourette syndrome
disease MESH Anxiety
drug DRUGBANK Clonidine
disease MESH relapses
disease MESH speech delay
disease MESH tic disorders
disease MESH phenotypic variability
disease MESH pathogenesis
pathway REACTOME Reproduction
disease MESH genetic disorders
disease MESH hyperphagia
disease MESH severe obesity
disease MESH haploinsufficiency
disease MESH mental disorder
disease MESH Tremor
drug DRUGBANK Neuropeptide Y

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *